Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure

G. Bourdier (Grenoble, France)

Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Session: New insights into the understanding of sleep and the consequences of sleep apnoea
Session type: Oral Presentation
Number: 1755
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Bourdier (Grenoble, France). Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure. 1755

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diaphragm dysfunction in isoproterenol-induced heart failure
Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Year: 2020


Role of mitochondria in the cardiac muscle from heart failure patients
Source: Annual Congress 2008 - Mitochondria in muscle-related respiratory disorders
Year: 2008


Impact of cardiac sympathetic denervation on IH-induced ischemic cardiomyopathy aggravation
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020


Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007


Zamicastat decreases cardiac arrhythmias in a rat model of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Paraquat-induced lung injury in rat presents altered pressor chemoreflex response probably due to vascular dysfunction
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Role of cardiac function in weaning failure
Source: International Consensus Conference in Intensive Care Medicine 2005
Year: 2005


Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats
Source: Eur Respir J 2012; 40: 1420-1429
Year: 2012



Hypoxia-induced right heart failure
Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease
Year: 2006



Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007


Moderate exercise training in monocrotaline treated rats accelerates the progression towards right ventricular heart failure
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007


Rosiglitazone impairs lung function in rats receiving isoproterenol and alone it decreases cardiac parasympathetic activity
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009


Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Effects of erythropoietin on advanced pulmonary vascular remodelling
Source: Eur Respir J 2008; 31: 126-134
Year: 2008



In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007



Theophylline increases muscle sympathetic activity in patients with congestive heart failure
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003


Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


Alveolar-capillary membrane dysfunction in heart failure: histopathological changes
Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Year: 2008